Skinvisible (SKVI) EPS (Weighted Average and Diluted) (2018 - 2024)
Skinvisible (SKVI) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.08 as the latest value for Q4 2024.
- Quarterly EPS (Weighted Average and Diluted) rose 233.33% to $0.08 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$0.11 through Dec 2024, up 78.43% year-over-year, with the annual reading at -$0.11 for FY2024, 78.85% up from the prior year.
- EPS (Weighted Average and Diluted) hit $0.08 in Q4 2024 for Skinvisible, up from -$0.06 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.08 in Q4 2024 to a low of -$0.33 in Q1 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.07 across 5 years, with a median of -$0.06 in 2021.
- Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 560.0% in 2023 and later surged 233.33% in 2024.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.07 in 2020, then surged by 39.08% to -$0.04 in 2021, then crashed by 125.0% to -$0.09 in 2022, then soared by 33.33% to -$0.06 in 2023, then soared by 233.33% to $0.08 in 2024.
- Business Quant data shows EPS (Weighted Average and Diluted) for SKVI at $0.08 in Q4 2024, -$0.06 in Q3 2024, and -$0.07 in Q2 2024.